EDC Cross-linking of Decellularized Tissue: A Promising Approach?

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Decellularization of xenografts creates promising tissue engineering scaffolds.
• Handling unfixed decellularized tissue is challenging.
• N-(3-dimethylaminopropyl)-N9-ethylcarbodiimide (EDC) is a biocompatible cross-linking alternative to glutaraldehyde (GA), usable for linking growth factors (GFs).

Purpose of the Study:

• To evaluate the efficacy of EDC cross-linking and GF coating on decellularized porcine aortic wall tissue.
• To assess the impact of EDC treatment on cellular infiltration, calcification, and tissue degradation.
• To compare the effects of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) in combination with EDC.

Main Methods:

• Porcine aortic wall tissue specimens were decellularized and treated with EDC.
• Specimens were coated with FGF or VEGF, or left untreated (control).
• Implantation in rats for 2, 4, and 6 weeks, followed by analysis of vital cells, cellular infiltration, macrophage infiltration, calcification, and tissue thickness.

Main Results:

• EDC treatment reduced vital cell reseeding and general cellular infiltration at early time points.
• No calcification was observed in any group.
• EDC and VEGF treatment showed the lowest macrophage infiltration and minimal tissue degradation.

Conclusions:

• EDC cross-linking combined with GF coating maintains the benefits of decellularized tissue.
• EDC and VEGF treatment demonstrates potential for improving decellularized aortic scaffolds.
• Further research is needed to evaluate performance under mechanical stress.